Identification of key differentially expressed mRNAs, miRNAs, lncRNAs, and circRNAs for Xp11 translocation renal cell carcinoma (RCC) based on Whole …

C Deng, C Wei, Y Hou, M Xiong, D Ni, Y Huang… - Genes, 2023 - mdpi.com
We carried out whole transcriptome sequencing (WTS) on the tumor and the matching
adjacent normal tissues from five patients having Xp11 translocation renal cell carcinoma …

MicroRNA expression profiling of Xp11 renal cell carcinoma

L Marchionni, M Hayashi, E Guida, A Ooki, E Munari… - Human pathology, 2017 - Elsevier
Renal cell carcinomas (RCCs) with Xp11 translocation (Xp11 RCC) constitute a distinctive
molecular subtype characterized by chromosomal translocations involving the Xp11. 2 …

NMRK2 is an efficient diagnostic indicator for Xp11. 2 translocation renal cell carcinoma

H Feng, S Cao, S Fu, J Liu, Y Gao… - The Journal of …, 2024 - Wiley Online Library
Xp11. 2 translocation renal cell carcinomas (tRCC) are a rare and highly malignant type of
renal cancer, lacking efficient diagnostic indicators and therapeutic targets. Through the …

Gene Expression Analysis of Aggressive Adult Xp11. 2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic …

JS Park, ME Lee, WS Jang, J Kim, SM Park, WS Ham - Biomedicines, 2022 - mdpi.com
Xp11. 2 translocation renal cell carcinoma (tRCC), involving transcription factor E3 (TFE3)
gene fusions, is a rare and aggressive RCC variant when present in adults and has been …

Xp11 translocation renal cell carcinoma and the mesenchymal counterparts: an evolving concept with novel insights on clinicopathologic features, prognosis …

XT Wang, QY Xia, XJ Zhou… - Critical Reviews™ in …, 2017 - dl.begellhouse.com
The TFE3 gene is one of four members of the micropathalima-associated transcription factor
family, along with TFEB, TFEC, and MiTF, located on chromosome Xp11. 2. The site is …

Comparative clinicopathologic characteristics and outcomes of paediatric and adult Xp11 translocation renal cell carcinomas: a retrospective multicentre study in …

W Ma, N Liu, W Zhuang, W Li, F Qu, J Sun, W Xu… - Scientific Reports, 2020 - nature.com
This study aimed to compare the clinicopathologic features and prognosis in patients with
Xp11 translocation renal cell carcinomas (RCCs). In total, 8083 RCCs were screened at five …

Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers

P Argani, J Hicks, AM De Marzo… - The American journal …, 2010 - journals.lww.com
Xp11 translocation renal cell carcinoma (RCC) harbor various TFE3 gene fusions, and are
known to underexpress epithelial immunohistochemical (IHC) markers such as cytokeratin …

Factors Associated with Survival From Xp11. 2 Translocation Renal Cell Carcinoma Diagnosis—A Systematic Review and Pooled Analysis

Y Wu, S Chen, M Zhang, K Liu, J Jing… - Pathology and …, 2021 - por-journal.com
Purpose: Xp11. 2 translocation renal cell carcinoma (Xp11. 2 tRCC) is a rare subtype of
renal cell carcinoma (RCC), characterized by translocations of Xp11. 2 breakpoints …

Xp11. 2 translocation renal cell carcinomas in young adults

L Xu, R Yang, W Gan, X Chen, X Qiu, K Fu, J Huang… - BMC urology, 2015 - Springer
Background Little is known about the biological behavior of Xp11. 2 translocation renal cell
carcinomas (RCCs) as few clinical studies have been performed using a large sample size …

[HTML][HTML] Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study

H Zou, X Kang, LJ Pang, W Hu, J Zhao… - … journal of clinical and …, 2014 - ncbi.nlm.nih.gov
To study the clinicopathological and genomic characteristics of Xp11. 2 translocation renal
cell carcinoma (Xp11. 2 RCC) in adults, we analyzed 9 Xp11. 2 RCCs, confirmed by …